期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 56, 期 4, 页码 254-263出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2010.05.008
关键词
acute myocardial infarction; percutaneous coronary intervention; NCDR
资金
- Merck/Schering-Plough Corporation
- Bristol-Myers Squibb/Sanofi Pharmaceutical
- Eli Lilly
- Bristol-Myers Squibb
- Sanofi-Aventis
- Merck/Schering-Plough
- GlaxoSmithKline
- Novartis
- AstraZeneca
- Accumetrics
- Intekrin Therapeutics
- Merck
- Takeda
- ACCF
- Oklahoma Foundation for Medical Quality
- Lilly
- Johnson Johnson